Neurogene Ownership | Who Owns Neurogene?
Neurogene Ownership Summary
Neurogene is owned by 109.48% institutional investors, 8.83% insiders. Samsara biocapital is the largest institutional shareholder, holding 11.09% of NGNE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.45% of its assets in Neurogene shares.
NGNE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurogene | 109.48% | 8.83% | -18.31% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 11.09% | $34.62M |
| Redmile group | 1.46M | 9.42% | $29.43M |
| Casdin capital | 1.42M | 9.17% | $28.63M |
| Rtw investments, lp | 1.36M | 8.80% | $27.47M |
| Ecor1 capital | 1.27M | 8.21% | $25.63M |
| Blackrock funding, inc. /de | 1.01M | 6.49% | $20.26M |
| Baker bros. advisors lp | 991.69K | 6.40% | $19.99M |
| Balyasny asset management | 718.39K | 4.64% | $14.48M |
| Toronto dominion bank | 681.34K | 4.40% | $13.74M |
| Jennison associates | 527.68K | 3.41% | $10.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 3.36% | $34.62M |
| Great point partners | 500.00K | 2.32% | $10.08M |
| Casdin capital | 1.42M | 2.17% | $28.63M |
| Redmile group | 1.46M | 1.95% | $29.43M |
| Ecor1 capital | 1.27M | 1.09% | $25.63M |
| Octagon capital advisors lp | 252.00K | 0.66% | $4.37M |
| Arrowmark colorado | 524.80K | 0.28% | $10.58M |
| Rtw investments, lp | 1.36M | 0.27% | $27.47M |
| Dafna capital management | 56.63K | 0.26% | $1.14M |
| Rock springs capital management lp | 104.34K | 0.12% | $2.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 382.65K | 0.00% | 252.32K |
| Great point partners | 500.00K | 2.32% | 150.00K |
| Millennium management | 204.81K | 0.00% | 133.49K |
| Casdin capital | 1.42M | 2.17% | 125.00K |
| Balyasny asset management | 718.39K | 0.02% | 109.81K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -446.88K |
| Commodore capital lp | - | - | -427.87K |
| Logos global management lp | - | - | -195.00K |
| Price t rowe associates inc /md/ | - | - | -123.29K |
| Deep track capital, lp | - | - | -116.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 69.71K | 0.00% | 69.71K | $1.41M |
| Quadrature capital | 16.83K | 0.00% | 16.83K | $291.97K |
| Mariner | 16.69K | 0.00% | 16.69K | $336.41K |
| Nomura | 12.72K | 0.00% | 12.72K | $256.52K |
| Aqr capital management | 10.31K | 0.00% | 10.31K | $207.87K |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -5.00 |
| Raymond james financial | -8.00 |
| Corecap advisors | -11.00 |
| Coldstream capital management | -20.00 |
| Signaturefd | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 97 | 3.19% | 16,958,112 | 2.74% | 109 | 1.80% | 62 | 63.16% | 15 | -50.00% |
| Dec 31, 2025 | 17 | -80.90% | 1,452,749 | -90.50% | 6 | 0.13% | 7 | -83.33% | 8 | -68.00% |
| Sep 30, 2025 | 26 | -67.50% | 1,140,405 | -92.30% | 5 | 0.11% | 13 | -64.86% | 7 | -74.07% |
| Jun 30, 2025 | 83 | -3.49% | 15,385,506 | 2.02% | 73 | 1.42% | 39 | -11.36% | 27 | 17.39% |
| Mar 31, 2025 | 88 | -3.30% | 16,456,922 | 3.74% | 78 | 0.90% | 45 | -22.41% | 23 | 43.75% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 382.19K | 2.45% | - |
| iShares Russell 2000 ETF | 268.96K | 1.72% | 2.26K |
| Fidelity Advisor Biotechnology I | 243.70K | 1.56% | 82.84K |
| Vanguard Institutional Extnd Mkt Idx Tr | 120.53K | 0.77% | - |
| Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 101.40K | 0.65% | 50.00 |
| Fidelity Small Cap Index | 96.28K | 0.62% | 1.02K |
| iShares Russell 2000 Value ETF | 95.34K | 0.61% | 511.00 |
| iShares Biotechnology ETF | 92.48K | 0.59% | 3.50K |
| Fidelity Enhanced Small Cap Core ETF | 80.80K | 0.52% | -936.00 |
| Meridian Small Cap Growth Legacy | 75.86K | 0.49% | -37.54K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 06, 2026 | Cvijic Christine Mikail | President and CFO | Sell | $155.69K |
| May 06, 2026 | Cvijic Christine Mikail | President and CFO | Sell | $144.35K |
| Mar 26, 2026 | Cvijic Christine Mikail | President and CFO | Sell | $55.32K |
| Mar 26, 2026 | McMinn Rachel | Chief Executive Officer | Sell | $74.00K |
| Mar 26, 2026 | Jordan Julie | Chief Medical Officer | Sell | $18.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 10 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 6 | - |
NGNE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools